Literature DB >> 20094714

Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology.

Regine Eibl1, Stephan Kaiser, Renate Lombriser, Dieter Eibl.   

Abstract

Disposable bioreactors have increasingly been incorporated into preclinical, clinical, and production-scale biotechnological facilities over the last few years. Driven by market needs, and, in particular, by the developers and manufacturers of drugs, vaccines, and further biologicals, there has been a trend toward the use of disposable seed bioreactors as well as production bioreactors. Numerous studies documenting their advantages in use have contributed to further new developments and have resulted in the availability of a multitude of disposable bioreactor types which differ in power input, design, instrumentation, and scale of the cultivation container. In this review, the term "disposable bioreactor" is defined, the benefits and constraints of disposable bioreactors are discussed, and critical phases and milestones in the development of disposable bioreactors are summarized. An overview of the disposable bioreactors that are currently commercially available is provided, and the domination of wave-mixed, orbitally shaken, and, in particular, stirred disposable bioreactors in animal cell-derived productions at cubic meter scale is reported. The growth of this type of reactor system is attributed to the recent availability of stirred disposable benchtop systems such as the Mobius CellReady 3 L Bioreactor. Analysis of the data from computational fluid dynamic simulation studies and first cultivation runs confirms that this novel bioreactor system is a viable alternative to traditional cell culture bioreactors at benchtop scale.

Mesh:

Year:  2010        PMID: 20094714     DOI: 10.1007/s00253-009-2422-9

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  32 in total

1.  Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors.

Authors:  Ruth Olmer; Andreas Lange; Sebastian Selzer; Cornelia Kasper; Axel Haverich; Ulrich Martin; Robert Zweigerdt
Journal:  Tissue Eng Part C Methods       Date:  2012-06-04       Impact factor: 3.056

2.  On-line monitoring of oxygen in Tubespin, a novel, small-scale disposable bioreactor.

Authors:  Kui Xie; Xiao-Wei Zhang; Li Huang; Yi-Ting Wang; Yun Lei; Jing Rong; Chui-Wen Qian; Qiu-Ling Xie; Yi-Fei Wang; An Hong; Sheng Xiong
Journal:  Cytotechnology       Date:  2011-05-17       Impact factor: 2.058

Review 3.  Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor.

Authors:  H Singh; J S E Moyes; M H Huls; L J N Cooper
Journal:  Cancer Gene Ther       Date:  2015-01-16       Impact factor: 5.987

4.  Disposable polymeric cryogel bioreactor matrix for therapeutic protein production.

Authors:  Era Jain; Ashok Kumar
Journal:  Nat Protoc       Date:  2013-04-04       Impact factor: 13.491

5.  On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.

Authors:  Jianfeng Xu; Ningning Zhang
Journal:  Pharm Bioprocess       Date:  2014-12-01

Review 6.  Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules.

Authors:  Sarah A Wilson; Susan C Roberts
Journal:  Plant Biotechnol J       Date:  2011-11-08       Impact factor: 9.803

7.  High yield of human monoclonal antibody produced by stably transfected Drosophila schneider 2 cells in perfusion culture using wave bioreactor.

Authors:  Lulan Wang; Hongxing Hu; Jianjun Yang; Feng Wang; Christian Kaisermayer; Paul Zhou
Journal:  Mol Biotechnol       Date:  2012-10       Impact factor: 2.695

Review 8.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

9.  High cell density cultivation and recombinant protein production with Escherichia coli in a rocking-motion-type bioreactor.

Authors:  Julia Glazyrina; Eva-Maria Materne; Thomas Dreher; Dirk Storm; Stefan Junne; Thorsten Adams; Gerhard Greller; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2010-05-30       Impact factor: 5.328

10.  The use of immobilized cytochrome P4502C9 in PMMA-based plug flow bioreactors for the production of drug metabolites.

Authors:  Lance A Wollenberg; Jarod L Kabulski; Matthew J Powell; Jifeng Chen; Darcy R Flora; Timothy S Tracy; Peter M Gannett
Journal:  Appl Biochem Biotechnol       Date:  2013-10-30       Impact factor: 2.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.